RESUMO
The integration of optoelectronic devices, such as transistors and photodetectors (PDs), into wearables and textiles is of great interest for applications such as healthcare and physiological monitoring. These require flexible/wearable systems adaptable to body motions, thus materials conformable to non-planar surfaces, and able to maintain performance under mechanical distortions. Here, fibre PDs are prepared by combining rolled graphene layers and photoactive perovskites. Conductive fibres (~500 Ωcm-1) are made by rolling single-layer graphene (SLG) around silica fibres, followed by deposition of a dielectric layer (Al2O3 and parylene C), another rolled SLG as a channel, and perovskite as photoactive component. The resulting gate-tunable PD has a response time~9ms, with an external responsivity~22kAW-1 at 488nm for a 1V bias. The external responsivity is two orders of magnitude higher, and the response time one order of magnitude faster, than state-of-the-art wearable fibre-based PDs. Under bending at 4mm radius, up to~80% photocurrent is maintained. Washability tests show~72% of initial photocurrent after 30 cycles, promising for wearable applications.
RESUMO
In the present study we investigae the effect of the previous injection of phentolamine (anonspecific alfa-adrenergic antagonist) into the lateral hypothalamus (LH) and lateral ventricle (LV) on the pressor and bradycardic responses produced by the injection of clonidine (an alfa-2 adrenergic agonist) into these same areas of conscious rats. The injections of clonidine into the LH produced pressor (39 ñ 5 and 38 ñ 3 mmHg, respectively) and bradycardic responses (-65 ñ 16 and -94 ñ 13 bpm, respectively). Previous injections of phentalamine into the LH or LV reduced the pressor response to clonidine injected into the same areas (DeltaMAP = 13 ñ 6 mmHg for LH and 1 ñ 3 mmHg for LV). No reduction was observed when clonidine was injected into the LV after the injection of phentalamine into the LH. No changes in bradycardic responses were observed after treatment with phentolamine. The present results show the participation of alfa-adrenergic receptors in the pressor response to centrally administered clonidine but not in the bradycardic reponse. The data also suggest that the pressor effect by the injection of clonidine into the LH is due to the activation of alfa-adrenergic receptors located specifically in this area. The pressor response after injection of clonidine into the LV and of phentolamine into the LH is due to the action of clonidine on other cerebral areas